EMCURE · Healthcare
The board meets on 3 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,663 cr | ₹1,668 cr | ₹1,771 cr | ₹1,815 cr | ₹2,002 cr | ₹1,963 cr | ₹2,116 cr | ₹2,101 cr | ₹2,270 cr | ₹2,363 cr | ₹2,470 cr | ₹2,580 cr |
| YoY | — | — | — | +17% | +20% | +18% | +19% | +16% | +13% | +20% | +17% | +23% |
| EBITDA margin | 19.8% | 17.6% | 17.6% | 18.5% | 19.0% | 18.1% | 19.0% | 19.8% | 20.9% | 20.9% | 19.4% | 20.6% |
| Other income, % of PBT | −1% | 13% | 7% | 11% | 13% | 2% | −2% | 0% | 1% | −11% | 4% | 1% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 26% | 30% | 27% | 26% | 26% | 32% | 24% | 26% | 26% | 26% | 29% | 26% |
| Net profit | ₹146 cr | ₹120 cr | ₹121 cr | ₹153 cr | ₹202 cr | ₹156 cr | ₹197 cr | ₹215 cr | ₹251 cr | ₹231 cr | ₹244 cr | ₹292 cr |
| YoY | — | — | — | +9% | +38% | +30% | +63% | +41% | +24% | +48% | +24% | +36% |
| Core profit YoY | — | — | — | +5% | +19% | +52% | +72% | +58% | +43% | +55% | +22% | +35% |
| EPS | ₹7.69 | ₹6.27 | ₹6.36 | ₹7.95 | ₹10.29 | ₹8.11 | ₹9.97 | ₹10.92 | ₹12.84 | ₹12.16 | ₹12.84 | ₹15.50 |
| Flags | · | · | · | ✓ | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.